表 2.
小鼠体内有限稀释实验检测二甲双胍对结直肠癌干细胞成瘤能力的影响
Limiting dilution assays on tumor-initiating frequencies (TIFs) of metformin-treated colorectal CSCs in vivo
No. | Gender | Age (year) | TNM stage | Group | Cell doses | TIFs (95% CI) | P | ||
104 | 103 | 102 | |||||||
TIFs: Tumor initiating frequencies. | |||||||||
PDO1 | Male | 48 | T3N2M0 | Control | 8/10 | 5/10 | 3/10 | 1/3110 (1/1551-1/6402) | < 0.001 |
Metformin | 3/10 | 1/10 | 0/10 | 1/23611 (1/8705-1/64038) | |||||
PDO2 | Female | 89 | T4aN0M0 | Control | 10/10 | 8/10 | 4/10 | 1/453 (1/227-1/905) | < 0.001 |
Metformin | 6/10 | 4/10 | 2/10 | 1/5896 (1/2972-1/11696) | |||||
PDO3 | Female | 59 | T4aN1M0 | Control | 10/10 | 7/10 | 4/10 | 1/576 (1/289-1/1149) | < 0.001 |
Metformin | 8/10 | 3/10 | 0/10 | 1/5218 (1/2639-1/10318) |